Correlation Engine 2.0
Clear Search sequence regions


  • adducts (1)
  • Amyloid (3)
  • baicalein (7)
  • drug design (1)
  • fibrils (1)
  • humans (1)
  • oxygen (1)
  • redox (1)
  • schiff base (4)
  • suggest (1)
  • Sizes of these terms reflect their relevance to your search.

    The oxidized form of baicalein (BA) leads to covalent binding with human amyloid proteins. Such adducts hamper the aggregation and deposition of fibrils. A novel reaction of BA with pentylamine (PA) as a model for the lysine side chain is described. This is the first study addressing the atomistic details of a Schiff base reaction with the trihydroxylated moiety of BA. Nuclear magnetic resonance and mass spectrometry approaches clearly indicate the formation of dehydrobaicalein in solution as well as its condensation with PA under aerobic conditions, yielding regioselectively C6-substituted products. The combined results suggest initial ion pair formation between BA and PA, followed by a redox chain reaction: the initiation by oxygen/air; an o-quinone-based chain involving oxidation and reduction steps; and extra off-chain formation of a doubly oxidized product. These mechanistic details support the anti-amyloid activity of BA and endorse its trihydroxyphenyl moiety as a pharmacophore for drug-design studies. © 2022 Wiley-VCH GmbH.

    Citation

    Natércia F Brás, Salavat S Ashirbaev, Hendrik Zipse. Combined in Silico and in Vitro Approaches To Uncover the Oxidation and Schiff Base Reaction of Baicalein as an Inhibitor of Amyloid Protein Aggregation. Chemistry (Weinheim an der Bergstrasse, Germany). 2022 Feb 19;28(11):e202104240

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 34989442

    View Full Text